Clinical Trial Update: Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

View source ↗

Summary

This post-marketing surveillance study evaluated the safety and tolerability of Sunitinib Malate (Sutent) in Filipino patients with metastatic renal cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma | Status: TERMINATED